Overview
- A pilot study published in PLOS One is the first to compare long COVID patients with fully recovered individuals, identifying distinct cognitive and biological differences.
- Long COVID patients showed significantly lower levels of nerve growth factor (NGF), a protein critical for brain plasticity and neuron health.
- Elevated levels of interleukin-10, an inflammatory marker, were observed in long COVID patients, suggesting persistent brain inflammation.
- Participants with long COVID exhibited lower performance in language fluency tests and reported decreased quality of life across physical, emotional, and psychological measures.
- Researchers advocate for larger-scale studies and recommend multidisciplinary care strategies, including speech therapy, stress reduction, and targeted medications, to address long COVID symptoms.